Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    today
    Change Detected
    Summary
    An HTML error page was added, making the study record unavailable. Several core content sections and sponsor/IPD-related items were removed from the page, reducing the information available about the study.
    Difference
    17%
    Check dated 2026-08-09T08:57:49.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4. This indicates an internal update to the page's metadata rather than any changes to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T16:42:27.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published revision of the record. This appears to be a small, internal version update with no visible changes to the study details or data.
    Difference
    0.0%
    Check dated 2026-07-04T04:17:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer software patch for the study record; there are no described content changes in this update.
    Difference
    0.0%
    Check dated 2026-06-27T02:48:41.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment section was updated; the heading was normalized from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag updated to v3.6.0 from v3.5.5. A note states that no participants are being recruited anymore, indicating enrollment is closed.
    Difference
    0.3%
    Check dated 2026-06-12T17:32:40.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.5.5) replacing the previous v3.5.4. This indicates a minor update to the page.
    Difference
    0.0%
    Check dated 2026-06-05T17:29:02.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.